Related Experiment Video
Updated: Feb 18, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Harnessing mucosal immunity for protective vaccines.
Dong-Il Kwon1,2,3, Sachin H Bhagchandani1,2, Stephen A Ehrenzeller1,2
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Mucosal vaccines delivered directly to body linings can generate localized immunity against pathogens. This review explores strategies to overcome challenges and enhance mucosal vaccine effectiveness for durable protection.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Mucosal surfaces are key entry points for pathogens.
- Parenteral vaccination often fails to induce effective mucosal immunity.
- Mucosal vaccines aim to enhance frontline defenses and localized immune responses.
Purpose of the Study:
- To review how mucosal vaccines elicit tissue-resident memory T and B cells.
- To discuss challenges in achieving sterilizing immunity at mucosal sites.
- To outline strategies for harnessing multilayered mucosal immunity for vaccine development.
Main Methods:
- Review of recent studies on mucosal vaccine-induced immunity.
- Analysis of immune-inductive and effector mechanisms in mucosal compartments.
- Discussion of emerging strategies for enhancing mucosal vaccine efficacy.
Main Results:
- Mucosal vaccines can elicit tissue-resident memory cells and local antibody secretion.
- Complex mucosal environments pose challenges to sterilizing immunity.
- Specialized immune mechanisms contribute to protective immunity at mucosal sites.
Conclusions:
- Developing effective mucosal vaccines requires understanding complex immune environments.
- Harnessing multilayered mucosal immunity is key to creating safe and durable vaccines.
- Further research into mucosal immune responses can improve vaccine strategies against infectious diseases.
More Related Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Vaccinations
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...